Evaluating the feasibility, effectiveness and costs of
implementing person-centred follow-up care for childhood cancer
survivors in four European countries: the PanCareFollowUp Care
prospective cohort study protocol

J 2022

Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol

VAN KALSBEEK REBECCA, J., Joke C KOREVAAR, Mieke RIJKEN, Riccardo HAUPT, Monica MURACA et. al.

Základní údaje

Originální název

Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol

Autoři

VAN KALSBEEK REBECCA, J. (garant), Joke C KOREVAAR, Mieke RIJKEN, Riccardo HAUPT, Monica MURACA, Tomáš KEPÁK (203 Česká republika, domácí), Kateřina KEPÁKOVÁ (203 Česká republika, domácí), Anne BLONDEEL, Stefan BOES, Line E FREDERIKSEN, Samira ESSIAF, Jeanette F WINTHER, Rosella P M G HERMENS, Anita KIENESBERGER, Jacqueline J LOONEN, Gisela MICHEL, Renee L MULDER, Kylie B BRIEN, J. H. VAN DER PAL HELENA, Saskia M F PLUIJM, Katharina ROSER, Roderick SKINNER, Marleen RENARD, Anne UYTTEBROECK, Cecilia FOLLIN, Lars HJORTH a Leontien C M KREMER

Vydání

BMJ Open, London, BMJ Publishing Group, 2022, 2044-6055

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.900

Kód RIV

RIV/00216224:14110/22:00128854

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1136/bmjopen-2022-063134

UT WoS

000924531200009

Klíčová slova anglicky

International health services; Health economics; Paediatric oncology; Organisation of health services

Štítky

14110321, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 10. 3. 2023 12:46, Mgr. Tereza Miškechová

Anotace

V originále

IntroductionLong-term survival after childhood cancer often comes at the expense of late, adverse health conditions. However, survivorship care is frequently not available for adult survivors in Europe. The PanCareFollowUp Consortium therefore developed the PanCareFollowUp Care Intervention, an innovative person-centred survivorship care model based on experiences in the Netherlands. This paper describes the protocol of the prospective cohort study (Care Study) to evaluate the feasibility and the health economic, clinical and patient-reported outcomes of implementing PanCareFollowUp Care as usual care in four European countries. Methods and analysisIn this prospective, longitudinal cohort study with at least 6months of follow-up, 800 childhood cancer survivors will receive the PanCareFollowUp Care Intervention across four study sites in Belgium, Czech Republic, Italy and Sweden, representing different healthcare systems. The PanCareFollowUp Care Intervention will be evaluated according to the Reach, Effectiveness, Adoption, Implementation and Maintenance framework. Clinical and research data are collected through questionnaires, a clinic visit for multiple medical assessments and a follow-up call. The primary outcome is empowerment, assessed with the Health Education Impact Questionnaire. A central data centre will perform quality checks, data cleaning and data validation, and provide support in data analysis. Multilevel models will be used for repeated outcome measures, with subgroup analysis, for example, by study site, attained age, sex or diagnosis. Ethics and disseminationThis study will be conducted in accordance with the guidelines of Good Clinical Practice and the Declaration of Helsinki. The study protocol has been reviewed and approved by all relevant ethics committees. The evidence and insights gained by this study will be summarised in a Replication Manual, also including the tools required to implement the PanCareFollowUp Care Intervention in other countries. This Replication Manual will become freely available through PanCare and will be disseminated through policy and press releases.

Citovat

VAN KALSBEEK REBECCA, J., Joke C KOREVAAR, Mieke RIJKEN, Riccardo HAUPT, Monica MURACA, Tomáš KEPÁK, Kateřina KEPÁKOVÁ, Anne BLONDEEL, Stefan BOES, Line E FREDERIKSEN, Samira ESSIAF, Jeanette F WINTHER, Rosella P M G HERMENS, Anita KIENESBERGER, Jacqueline J LOONEN, Gisela MICHEL, Renee L MULDER, Kylie B BRIEN, J. H. VAN DER PAL HELENA, Saskia M F PLUIJM, Katharina ROSER, Roderick SKINNER, Marleen RENARD, Anne UYTTEBROECK, Cecilia FOLLIN, Lars HJORTH a Leontien C M KREMER. Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol. BMJ Open. London: BMJ Publishing Group, 2022, roč. 12, č. 11, s. 1-10. ISSN 2044-6055. Dostupné z: https://dx.doi.org/10.1136/bmjopen-2022-063134.

@article{2266203,
   author = {van Kalsbeek Rebecca, J. and Korevaar, Joke C and Rijken, Mieke and Haupt, Riccardo and Muraca, Monica and Kepák, Tomáš and Kepáková, Kateřina and Blondeel, Anne and Boes, Stefan and Frederiksen, Line E and Essiaf, Samira and Winther, Jeanette F and Hermens, Rosella P M G and Kienesberger, Anita and Loonen, Jacqueline J and Michel, Gisela and Mulder, Renee L and Brien, Kylie B and van der Pal Helena, J. H. and Pluijm, Saskia M F and Roser, Katharina and Skinner, Roderick and Renard, Marleen and Uyttebroeck, Anne and Follin, Cecilia and Hjorth, Lars and Kremer, Leontien C M},
   article_location = {London},
   article_number = {11},
   doi = {http://dx.doi.org/10.1136/bmjopen-2022-063134},
   keywords = {International health services; Health economics; Paediatric oncology; Organisation of health services},
   language = {eng},
   issn = {2044-6055},
   journal = {BMJ Open},
   title = {Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol},
   url = {https://bmjopen.bmj.com/content/12/11/e063134},
   volume = {12},
   year = {2022}
}

TY  - JOUR
ID  - 2266203
AU  - van Kalsbeek Rebecca, J. - Korevaar, Joke C - Rijken, Mieke - Haupt, Riccardo - Muraca, Monica - Kepák, Tomáš - Kepáková, Kateřina - Blondeel, Anne - Boes, Stefan - Frederiksen, Line E - Essiaf, Samira - Winther, Jeanette F - Hermens, Rosella P M G - Kienesberger, Anita - Loonen, Jacqueline J - Michel, Gisela - Mulder, Renee L - Brien, Kylie B - van der Pal Helena, J. H. - Pluijm, Saskia M F - Roser, Katharina - Skinner, Roderick - Renard, Marleen - Uyttebroeck, Anne - Follin, Cecilia - Hjorth, Lars - Kremer, Leontien C M
PY  - 2022
TI  - Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol
JF  - BMJ Open
VL  - 12
IS  - 11
SP  - 1-10
EP  - 1-10
PB  - BMJ Publishing Group
SN  - 20446055
KW  - International health services
KW  - Health economics
KW  - Paediatric oncology
KW  - Organisation of health services
UR  - https://bmjopen.bmj.com/content/12/11/e063134
N2  - IntroductionLong-term survival after childhood cancer often comes at the expense of late, adverse health conditions. However, survivorship care is frequently not available for adult survivors in Europe. The PanCareFollowUp Consortium therefore developed the PanCareFollowUp Care Intervention, an innovative person-centred survivorship care model based on experiences in the Netherlands. This paper describes the protocol of the prospective cohort study (Care Study) to evaluate the feasibility and the health economic, clinical and patient-reported outcomes of implementing PanCareFollowUp Care as usual care in four European countries. Methods and analysisIn this prospective, longitudinal cohort study with at least 6months of follow-up, 800 childhood cancer survivors will receive the PanCareFollowUp Care Intervention across four study sites in Belgium, Czech Republic, Italy and Sweden, representing different healthcare systems. The PanCareFollowUp Care Intervention will be evaluated according to the Reach, Effectiveness, Adoption, Implementation and Maintenance framework. Clinical and research data are collected through questionnaires, a clinic visit for multiple medical assessments and a follow-up call. The primary outcome is empowerment, assessed with the Health Education Impact Questionnaire. A central data centre will perform quality checks, data cleaning and data validation, and provide support in data analysis. Multilevel models will be used for repeated outcome measures, with subgroup analysis, for example, by study site, attained age, sex or diagnosis. Ethics and disseminationThis study will be conducted in accordance with the guidelines of Good Clinical Practice and the Declaration of Helsinki. The study protocol has been reviewed and approved by all relevant ethics committees. The evidence and insights gained by this study will be summarised in a Replication Manual, also including the tools required to implement the PanCareFollowUp Care Intervention in other countries. This Replication Manual will become freely available through PanCare and will be disseminated through policy and press releases.
ER  -

VAN KALSBEEK REBECCA, J., Joke C KOREVAAR, Mieke RIJKEN, Riccardo HAUPT, Monica MURACA, Tomáš KEPÁK, Kateřina KEPÁKOVÁ, Anne BLONDEEL, Stefan BOES, Line E FREDERIKSEN, Samira ESSIAF, Jeanette F WINTHER, Rosella P M G HERMENS, Anita KIENESBERGER, Jacqueline J LOONEN, Gisela MICHEL, Renee L MULDER, Kylie B BRIEN, J. H. VAN DER PAL HELENA, Saskia M F PLUIJM, Katharina ROSER, Roderick SKINNER, Marleen RENARD, Anne UYTTEBROECK, Cecilia FOLLIN, Lars HJORTH a Leontien C M KREMER. Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol. \textit{BMJ Open}. London: BMJ Publishing Group, 2022, roč.~12, č.~11, s.~1-10. ISSN~2044-6055. Dostupné z: https://dx.doi.org/10.1136/bmjopen-2022-063134.

Podrobný výpis o publikaci